We are live on
!
Find out more
TIP
Tandem Investment Partners Portfolio holdings
AUM
$130M
1-Year Est. Return
18.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.03%
1 Year Est. Return
+18.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$3.13M
(-2.6%)
Cap. Flow
-$5.13M
Cap. Flow
% of AUM
-4.33%
Top 10 Holdings %
Top 10 Hldgs %
45.72%
Holding
71
New
2
Increased
15
Reduced
51
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
|
+$1.17M |
| 2 |
Vanguard Core Bond ETF
VCRB
|
+$858K |
| 3 |
Gilead Sciences
GILD
|
+$259K |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$245K |
| 5 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$228K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$1.35M |
| 2 |
Vanguard Information Technology ETF
VGT
|
+$556K |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$401K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$390K |
| 5 |
JPMorgan Chase
JPM
|
+$359K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.12% |
| 2 | Financials | 5.03% |
| 3 | Healthcare | 2.98% |
| 4 | Consumer Staples | 2.27% |
| 5 | Communication Services | 2.07% |
Similar funds
DSC
RHIG
CG
BM
NCM
MWM
EPCA
CWAI
Tandem Investment Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Tandem Investment Partners held 71 positions worth $119M, down 2.6% from $122M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Tandem Investment Partners withdrew a net $5.13M in Q4 2025, closing 1 position and reducing 51 holdings. Its most notable exit was Pfizer, an estimated $289K position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Tandem Investment Partners opened a new position in Gilead Sciences worth $261K.
- Tandem Investment Partners's largest Q4 2025 buy was Gilead Sciences: 2,130 shares worth $261K.
- Tandem Investment Partners added most to Pacer US Large Cap Cash Cows Growth Leaders ETF in Q4 2025, an estimated $1.17M increase.
- Tandem Investment Partners's biggest Q4 2025 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $1.35M.
- Tandem Investment Partners fully exited Pfizer in Q4 2025, selling an estimated $289K.
- Tandem Investment Partners's ten largest holdings make up 46% of its $119M portfolio in Q4 2025.
- Tandem Investment Partners opened 2 new positions and closed 1 in Q4 2025.
- Tandem Investment Partners's portfolio value fell 2.6% quarter-over-quarter to $119M.
Based on Tandem Investment Partners's 13F filing for Q4 2025, filed 21 Jan 2026.